/ /

Lynda Charters
High myopia: Global pandemic with genetic and environmental causes
Singapore—The manner in which myopia works has been a mystery until recently when investigators began making inroads into how the disease progresses. This knowledge likely is going to result in lifestyle changes, said Jodhbir Mehta, MBBS, PhD.
Trends in U.S. refractive surgery: 2015 ISRS survey
The 2015 International Society of Refractive Surgery survey, the twentieth such survey and the seventh year published online, presents new findings about surgeons’ preferences in corneal and lens-based surgeries, premium intraocular lenses (IOLs), and femtosecond cataract surgery.
Imaging, 27-gauge systems capture retina surgeons’ focus
Retina surgeons considered 2015 to be an exciting time in the subspecialty in all areas and pointed to the availability and increased use of 27-gauge instrumentation as one of the real highlights of surgical retina.
Year brings advances in retinal imaging, screening, and gene/drug therapies
The topics of special interest to retina specialists during 2015 include optical coherence tomography angiography (OCTA) and screening for retinopathy of prematurity (ROP). Important research is taking place to determine the etiology of angiogenesis, possibly leading to targeting therapies in age-related macular degeneration (AMD), ROP, and diabetic retinopathy.
DRCR.net retinal treatment results take center stage in 2015
Studies of the efficacy of anti-vascular endothelial growth factor (VEGF), gene therapies, and slow-release drug delivery systems took center stage among treatments for retinal disorders in 2015. In addition to studies already under way, others are about to begin.
Red light technology increases tear break-up time in dry eye patients
Treatment with red light technology resulted in a significant improvement in the tear break-up time in the vast majority of patients. This may be a future light treatment for the improvement of dry eye disease in patients with meibomian gland dysfunction.
Topical integrin antagonist lifitegrast safely treats dry eye disease
Lifitegrast ophthalmic solution 5.0% (Shire Pharmaceuticals) administered twice daily for 1 year appeared safe and well-tolerated with no unexpected adverse events in a study.
Natural oral omega-3 supplement improves dry eye parameters in 3 months
The natural triglyceride form of omega-3 is an excellent treatment option for dry eye disease.
Rethinking the EHR system: The most important components
Documenting practice flow and needs is a critical step in preparation for choosing or replacing an electronic health record system.
Anti-VEGF drugs: Safe and effective for treating DME
Data from large randomized trials indicate that diabetic macular edema can be treated safely and effectively with anti-vascular endothelial growth factor therapies.